GlassScriptPhysician profile
Brittny A White
NPI 1043735335
$17,082.52
in general payments reported to CMS, 2019-2025
28 companies · $3,628 in 2025
The $3,628 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,771 · 2022: $2,438 · 2023: $3,431 · 2024: $5,815 · 2025: $3,628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $1,123 · Consulting Fee: $987 · Education: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,439.57 |
| Travel and Lodging | $1,123.22 |
| Consulting Fee | $987.00 |
| Education | $324.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,819.26 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $3,150.58 | 2022-2025 | Sotyktu |
| Janssen Biotech, INC. | $1,594.15 | 2021-2025 | Tremfya, Stelara, Simponi |
| Novartis Pharmaceuticals Corporation | $1,587.81 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,479.71 | 2021-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $1,011.41 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $723.78 | 2022-2025 | Ilumya, Winlevi, Absorica Ld |
| Ucb, INC. | $628.26 | 2021-2025 | Bimzelx |
| Leo Pharma INC. | $597.81 | 2022-2025 | Adbry |
| Galderma Laboratories, L.P. | $461.04 | 2022-2025 | Nemluvio, Dysport, Epsolay |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $348.38 | 2021-2024 | Siliq, Duobrii, Targretin |
| Lilly USA, LLC | $337.08 | 2021-2024 | Olumiant, Taltz |
| Pfizer INC. | $330.54 | 2021-2025 | |
| Incyte Corporation | $277.00 | 2021-2024 | |
| Amgen INC. | $202.58 | 2021-2025 | Otezla, Otezla |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $139.86 | 2024 | Zoryve |
| Janssen Scientific Affairs, LLC | $113.56 | 2022 | |
| Allergan, INC. | $71.94 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.59 | 2022-2025 | Spevigo |
| Merz North America, INC. | $30.66 | 2025 | |
| Mallinckrodt Hospital Products INC. | $27.85 | 2025 | Acthar |
| Mylan Institutional INC. | $22.47 | 2023 | Hulio |
| Botanix Sb INC | $18.72 | 2025 | Sofdra |
| Organon LLC | $15.20 | 2025 | Vtama |
| Verrica Pharmaceuticals INC. | $14.79 | 2023 | Ycanth |
| Dermavant Sciences, INC. | $13.81 | 2023 | Vtama |
| Mayne Pharma Commercial LLC | $13.26 | 2024 | |
| Biofrontera INC. | $12.42 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittny White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.